As of 2024-12-13, the Intrinsic Value of Phibro Animal Health Corp (PAHC) is
16.64 USD. This PAHC valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 23.88 USD, the upside of Phibro Animal Health Corp is
-30.30%.
The range of the Intrinsic Value is 6.86 - 57.14 USD
16.64 USD
Intrinsic Value
PAHC Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
6.86 - 57.14 |
16.64 |
-30.3% |
| DCF (Growth 10y) |
8.23 - 56.55 |
17.69 |
-25.9% |
| DCF (EBITDA 5y) |
11.10 - 17.47 |
14.17 |
-40.7% |
| DCF (EBITDA 10y) |
11.55 - 19.16 |
15.12 |
-36.7% |
| Fair Value |
2.15 - 2.15 |
2.15 |
-91.00% |
| P/E |
2.20 - 8.77 |
4.87 |
-79.6% |
| EV/EBITDA |
16.13 - 24.77 |
19.29 |
-19.2% |
| EPV |
2.76 - 6.90 |
4.83 |
-79.8% |
| DDM - Stable |
4.12 - 13.57 |
8.85 |
-63.0% |
| DDM - Multi |
2.27 - 5.14 |
3.08 |
-87.1% |
PAHC Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
967.14 |
| Beta |
0.88 |
| Outstanding shares (mil) |
40.50 |
| Enterprise Value (mil) |
1,389.47 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.57% |
| Cost of Debt |
4.54% |
| WACC |
6.60% |